10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Price-to-Tangible-Book : 6.87 (As of May. 09, 2024)

View and export this data going back to 2022. Start your Free Trial

What is 10X Capital Venture Acquisition III Price-to-Tangible-Book?

As of today (2024-05-09), 10X Capital Venture Acquisition III's share price is $10.93. 10X Capital Venture Acquisition III's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was $1.59. Hence, 10X Capital Venture Acquisition III's Price to Tangible Book Ratio of today is 6.87.

The historical rank and industry rank for 10X Capital Venture Acquisition III's Price-to-Tangible-Book or its related term are showing as below:

VCXB' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.41 Med: 5.61 Max: 6.87
Current: 6.87

During the past 2 years, 10X Capital Venture Acquisition III's highest Price to Tangible Book Ratio was 6.87. The lowest was 1.41. And the median was 5.61.

VCXB's Price-to-Tangible-Book is ranked worse than
87.38% of 507 companies
in the Diversified Financial Services industry
Industry Median: 1.83 vs VCXB: 6.87

A closely related ratio is called PB Ratio. As of today, 10X Capital Venture Acquisition III's share price is $10.93. 10X Capital Venture Acquisition III's Book Value per Sharefor the quarter that ended in Sep. 2023 was $1.59. Hence, 10X Capital Venture Acquisition III's P/B Ratio of today is 6.87.

10X Capital Venture Acquisition III Price-to-Tangible-Book Historical Data

The historical data trend for 10X Capital Venture Acquisition III's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

10X Capital Venture Acquisition III Price-to-Tangible-Book Chart

10X Capital Venture Acquisition III Annual Data

Trend

Dec21

Dec22

Price-to-Tangible-Book

5.88

10X Capital Venture Acquisition III Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Price-to-Tangible-Book	Get a 7-Day Free Trial						1.42	5.88	5.61	6.07	6.73

Competitive Comparison of 10X Capital Venture Acquisition III's Price-to-Tangible-Book

For the Shell Companies subindustry, 10X Capital Venture Acquisition III's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

10X Capital Venture Acquisition III's Price-to-Tangible-Book Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, 10X Capital Venture Acquisition III's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where 10X Capital Venture Acquisition III's Price-to-Tangible-Book falls into.

10X Capital Venture Acquisition III Price-to-Tangible-Book Calculation

10X Capital Venture Acquisition III's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2023 )
	=	10.93	/	1.591
	=	6.87

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

10X Capital Venture Acquisition III Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of 10X Capital Venture Acquisition III's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » 10X Capital Venture Acquisition Corp III (AMEX:VCXB) » Definitions » Price-to-Tangible-Book

Comparable Companies

BCSA LCW GAQ FLME CHEA EVE HCMA SUAC ALCY HHLA PBAJ SVMB SCRM CVII AAC GHIX ALCC AACT DWAC SAGA

Traded in Other Exchanges

N/A

Address

1 World Trade Center, 85th Floor, New York, NY, USA, 10007

Website

https://www.10xspac.com

10X Capital Venture Acquisition Corp III is a blank check company.

Executives

Kash Sheikh	director	4001 KENNETT PIKE, SUITE 302, WILMINGTON DE 19807
Woodrow Levin	director	535 MISSION STREET, 11TH FLOOR, SAN FRANSISCO CA 941105
Christopher Jurasek	director	13625 TECHNOLOGY DR, EDEN PRAIRIE MN 55344-2252
Oliver Wriedt	officer: See Remarks	CIFC CORP., 250 PARK AVENUE, 4TH FLOOR, NEW YORK NY 10177
David Weisburd	director, officer: COO & Head of Origination	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
Guhan Kandasamy	officer: Chief Financial Officer	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
Hans Thomas	director, 10 percent owner, officer: Chief Executive Officer	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
Boris Silver	director	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NY 10007
10x Capital Advisors, Llc	10 percent owner	1 WORLD TRADE CENTER, 85TH FLOOR, NEW YORK NY 10007
10x Capital Spac Sponsor Iii Llc	director, 10 percent owner	1 WORLD TRADE CENTER, FLOOR 85, NEW YORK NJ 10007

10X Capital Venture Acquisition III (10X Capital Venture Acquisition III) Headlines

From GuruFocus

Correction: Addimmune, a Clinical Stage HIV-Focused Gene Therapy Company, to go Public Through Business Combination With 10X Capital Venture Acquisition Corp. III

By GlobeNewswire • 08-10-2023